Antitumor efficacy of lidamycin on hepatoma and active moiety of its molecule

Por Huang, Yun-Hong, Shang, Bo-Yang, Zhen, Yong-Su
Publicado no World J Gastroenterol (2005)

Lidamycin shows highly potent cytotoxic to myeloma cells and inhibits tumor growth in mice

Por Zhen, Yong-zhan, Lin, Ya-jun, Li, Yi, Zhen, Yong-su
Publicado em 2009

Activity of boanmycin against colorectal cancer

Por Deng, Yong Chuan, Zhen, Yong Su, Zheng, Shu, Xue, Yu Chuan
Publicado no World J Gastroenterol (2001)

A Multifunctional Drug Combination Shows Highly Potent Therapeutic Efficacy against Human Cancer Xenografts in Athymic Mice

Por Liu, Xiu-Jun, Zheng, Yan-Bo, Li, Yi, Wu, Shu-Ying, Zhen, Yong-Su
Publicado no PLoS One (2014)

An EGFR/HER2-Bispecific and Enediyne-Energized Fusion Protein Shows High Efficacy against Esophageal Cancer

Por Guo, Xiao-Fang, Zhu, Xiao-Fei, Yang, Wan-Cai, Zhang, Sheng-Hua, Zhen, Yong-Su
Publicado em 2014

Antitumor activity of anti-type IV collagenase monoclonal antibody and its lidamycin conjugate against colon carcinoma

Por Li, Liang, Huang, Yun-Hong, Li, Yi, Wang, Feng-Qiang, Shang, Bo-Yang, Zhen, Yong-Su
Publicado no World J Gastroenterol (2005)

Small antibody fusion proteins with complementarity-determining regions and lidamycin for tumor targeting therapy

Por ZHONG, GEN-SHEN, WU, MIN-NA, GUO, XIAO-FANG, XU, ZHI-SHAN, ZHANG, SHENG-HUA, ZHEN, YONG-SU
Publicado em 2013

Synergistic inhibition of angiogenesis and glioma cell-induced angiogenesis by the combination of temozolomide and enediyne antibiotic lidamycin

Por Li, Xing-qi, Ouyang, Zhi-gang, Zhang, Sheng-hua, Liu, Hong, Shang, Yue, Li, Yi, Zhen, Yong-su
Publicado em 2014

An engineered TIMP2-based and enediyne-integrated fusion protein for targeting MMP-14 shows potent antitumor efficacy

Por Xu, Jian, Liu, Xiu-Jun, Li, Liang, Zhang, Sheng-Hua, Li, Yi, Gao, Rui-Juan, Zhen, Yong-Su
Publicado no Oncotarget (2015)

A new HDAC inhibitor cinnamoylphenazine shows antitumor activity in association with intensive macropinocytosis

Por Zhu, Bing-yan, Shang, Bo-yang, Du, Yue, Li, Yi, Li, Liang, Xu, Xian-dong, Zhen, Yong-su
Publicado no Oncotarget (2017)

A recombinantly tailored β-defensin that displays intensive macropinocytosis-mediated uptake exerting potent efficacy against K-Ras mutant pancreatic cancer

Por Du, Yue, Shang, Bo-yang, Sheng, Wei-jin, Zhang, Sheng-hua, Li, Yi, Miao, Qing-fang, Zhen, Yong-su
Publicado no Oncotarget (2016)

Genetically engineered endostatin-lidamycin fusion proteins effectively inhibit tumor growth and metastasis

Por Jiang, Wen-guo, Lu, Xin-an, Shang, Bo-yang, Fu, Yan, Zhang, Sheng-hua, Zhou, Daifu, Li, Liang, Li, Yi, Luo, Yongzhang, Zhen, Yong-su
Publicado em 2013

EZH2 mediates lidamycin-induced cellular senescence through regulating p21 expression in human colon cancer cells

Por Sha, Ming-Quan, Zhao, Xiao-Li, Li, Liang, Li, Li-Hui, Li, Yi, Dong, Tian-Geng, Niu, Wei-Xin, Jia, Li-Jun, Shao, Rong-Guang, Zhen, Yong-Su, Wang, Zhen
Publicado no Cell Death Dis (2016)

A Novel Nitrobenzoate Microtubule Inhibitor that Overcomes Multidrug Resistance Exhibits Antitumor Activity

Por Zheng, Yan-Bo, Gong, Jian-Hua, Liu, Xiu-Jun, Wu, Shu-Ying, Li, Yi, Xu, Xian-Dong, Shang, Bo-Yang, Zhou, Jin-Ming, Zhu, Zhi-Ling, Si, Shu-Yi, Zhen, Yong-Su
Publicado no Sci Rep (2016)